Proteome Sciences PLC
FINPROM Findings
2“returns against the fast rate of growth projected for Proteomics to 2030... Vulpes Life Science Fund, the Company's major shareholder, and Richard Dennis, the Company's Chief Commercial Officer... subscribed for 17,142,857 Fundraise Shares”
Director and major shareholder (Vulpes, co-founded by NED Martin Diggle) dominate the fundraise with 18.57m of the 48m shares, representing 39% of the raise. The unqualified projection 'fast rate of growth projected for Proteomics to 2030' in a fundraising announcement lacks sufficient caveats.
“Retail Offer opens 26/01/2026, 7:30 a.m... Retail Offer is expected to close at 12:00 p.m. on 28 January 2026... The Retail Offer may close early if it is oversubscribed”
Retail offer window of only 2 calendar days (1.5 business days) for a £60,000 raise with an early-close provision if oversubscribed. The very small raise amount and tight window together limit meaningful retail participation.
RNS Announcements
2£840,000 Fundraise and Retail Offer
This Announcement does not constitute a prospectus or offering memorandum or an offer in respect of any securities and is not intended to provide the basis for any investment decision in respect of Proteome Sciences plc or other evaluation of any securities of Proteome Sciences plc or any other entity and should not be considered as a recommendation that any investor should subscribe for or purchase any such securities . This Announcement contains inside information for the purposes of Article 14 of the UK version of the market abuse regulation (EU No .596/2014) as it forms part of United Ki…
Retail Offer to raise up to £60,000
THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF PROTEOME SCIENCES PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY BY SUCH PERSONS. THIS ANNOUNCEMENT IS FOR INF…
LinkedIn Activity
1More Exciting News! BookBuild is thrilled to announce the successful conclusion of the latest Retail Offer for Proteome Sciences plc which was significantly oversubscribed. Thanks to SP Angel.
BookBuild's own company page uses promotional language ('Exciting News!', 'thrilled', 'significantly oversubscribed') without any risk disclaimers. Contrast with RetailBook's posts which include risk warnings.
Board of Directors
7| Name | Role | Appointed | Status |
|---|---|---|---|
| Christopher Donovan James Pearce | Non-Executive Director | 1994-07-13 | active |
| Dr Ian Hugo Pike | Executive Director | 2010-09-30 | active |
| Dr Ursula Mary Ney | Non-Executive Director | 2017-08-01 | active |
| Martin Henry Diggle | Non-Executive Director | 2014-10-16 | active |
| Richard Paul Dennis | Executive Director | 2018-04-24 | active |
| Roger Steven McDowell | Non-Executive Director | 2014-07-01 | active |
| Victoria Joanna Birse | Director | 2017-08-01 | active |